These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 158056)

  • 1. Lepromin-induced suppressor cells in patients with leprosy.
    Mehra V; Mason LH; Fields JP; Bloom BR
    J Immunol; 1979 Oct; 123(4):1813-7. PubMed ID: 158056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lepromin-induced suppressor cells in lepromatous leprosy.
    Nelson EE; Wong L; Uyemura K; Rea TH; Modlin RL
    Cell Immunol; 1987 Jan; 104(1):99-104. PubMed ID: 2948676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK
    J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concanavalin A induced suppressor activity in human leprosy.
    Nath I; Narayanan RB; Mehra NK; Sharma AK; Gupte MD
    J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on T cell subsets and functions in leprosy.
    Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
    Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated suppressor T cells in leprosy.
    Mehra V; Convit J; Rubinstein A; Bloom BR
    J Immunol; 1982 Nov; 129(5):1946-51. PubMed ID: 6214583
    [No Abstract]   [Full Text] [Related]  

  • 7. Lepromin-induced lymphoproliferative response of experimental leprosy monkeys: regulatory role of monocyte and lymphocyte subsets.
    Ohkawa S; Martin LN; Gormus BJ
    J Immunol; 1987 Jun; 138(11):3943-8. PubMed ID: 2953794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor response in lepromatous leprosy patients: role of Leu 2a cells.
    del Carmen Sasiain M; de la Barrera S; Ruibal-Ares B; Cardama JE; Gatti JC; de Bracco MM
    Immunology; 1987 Jan; 60(1):13-8. PubMed ID: 2950048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
    Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
    Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.
    González-Amaro R; Salazar-González JF; Baranda L; Abud-Mendoza C; Moncada B; García R; Alcocer-Varela J
    Clin Exp Immunol; 1988 Mar; 71(3):399-404. PubMed ID: 3133142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.
    Rea TH
    Clin Exp Immunol; 1983 Nov; 54(2):298-304. PubMed ID: 6228349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
    Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
    Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.
    Mehra V; Mason LH; Rothman W; Reinherz E; Schlossman SF; Bloom BR
    J Immunol; 1980 Sep; 125(3):1183-8. PubMed ID: 6997379
    [No Abstract]   [Full Text] [Related]  

  • 19. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-2 production by adherent cell factors from lepromatous leprosy patients.
    Nath I; Jayaraman J; Sathish M; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):531-8. PubMed ID: 6334579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.